$TOCKHOLDER ALERT: The M&A Class Action Firm Urges Shareholders of PFIE, PSTX, ARCH, B to Take Action
December 18, 2024 17:00 ET
|
Monteverde & Associates PC
NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm...
$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of ARCH, USAP, CFB, and BRKH
December 10, 2024 17:59 ET
|
Monteverde & Associates PC
NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm...
$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of ARCH, USAP, CYTH, and BRKH
December 05, 2024 12:00 ET
|
Monteverde & Associates PC
NEW YORK, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm...
$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of MKFG, CFB, and ARCH
November 22, 2024 17:45 ET
|
Monteverde & Associates PC
NEW YORK, Nov. 22, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by...
Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)
October 01, 2024 14:24 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Arch Resources, Inc. – ARCH
August 21, 2024 12:12 ET
|
Monteverde & Associates PC
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022...
Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)
April 25, 2023 06:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., April 25, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Dedicated HCPCS Billing Code for Arch Therapeutics’ AC5® Advanced Wound System Now In Effect
April 05, 2023 06:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...